Health equity considerations in pragmatic trials in Alzheimer's and dementia disease: Results from a methodological review.

Stuart G NichollsAhmed A Al-JaishiHarrison NiznickKelly CarrollMohamad Tarek MadaniKatherine D PeakLeen MadaniPascale NevinsLionel AdissoFan LiCharles WeijerSusan L MitchellVivian WelchAna R QuiñonesMonica Taljaard

Published in: Alzheimer's & dementia (Amsterdam, Netherlands) (2023)

Few pragmatic trials are explicitly designed to inform equity-relevant objectives.Few pragmatic trials take steps to increase enrollment from equity-relevant groups.Disaggregated results across equity-relevant groups are seldom reported.Adherence to existing tools (e.g., IMPACT Best Practices, CONSORT-Equity) is key.

Keyphrases

global health
healthcare
study protocol
public health
primary care
mild cognitive impairment
randomized controlled trial
type diabetes
health insurance
metabolic syndrome
cognitive impairment
health information
climate change
skeletal muscle
affordable care act
health promotion